|
gptkbp:instanceOf
|
anabolic steroid
androgen ester
|
|
gptkbp:abusePotential
|
yes
|
|
gptkbp:administeredBy
|
gptkb:dog
gptkb:livestock
horses
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:brand
|
gptkb:Equipoise
Parenabol
|
|
gptkbp:CASNumber
|
13103-34-9
|
|
gptkbp:chemicalFormula
|
C30H44O3
|
|
gptkbp:compatibleWith
|
human use in the United States
|
|
gptkbp:controlledSubstanceSchedule
|
yes (in many countries)
|
|
gptkbp:derivedFrom
|
gptkb:boldenone
|
|
gptkbp:detectionInSport
|
urine testing
|
|
gptkbp:developedBy
|
gptkb:Ciba
|
|
gptkbp:eliminationHalfLife
|
14 days (intramuscular)
|
|
gptkbp:esterGroup
|
undecylenate
|
|
gptkbp:excretion
|
renal
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Boldenone undecylenate
|
|
gptkbp:introduced
|
1960s
|
|
gptkbp:IUPACName
|
(17β)-17-hydroxyandrost-1,4-dien-3-one undec-10-enoate
|
|
gptkbp:KEGGID
|
D03077
|
|
gptkbp:legalStatus
|
prescription only (varies by country)
|
|
gptkbp:mechanismOfAction
|
androgen receptor agonist
|
|
gptkbp:MeSH_ID
|
C005703
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
452.67 g/mol
|
|
gptkbp:notableFor
|
long-acting injectable anabolic steroid
|
|
gptkbp:PubChem_CID
|
180870
208353
CHEMBL1200707
|
|
gptkbp:relatedTo
|
gptkb:nandrolone
testosterone
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
acne
increased appetite
virilization
increased aggression
|
|
gptkbp:structure
|
Δ1 double bond
|
|
gptkbp:synonym
|
1,4-androstadiene-3-one,17β-ol undecylenate
Δ1-testosterone undecylenate
|
|
gptkbp:UNII
|
8N287C1KLF
|
|
gptkbp:usedFor
|
improving weight gain in animals
treating debilitation in animals
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
|
|
gptkbp:WADA_status
|
prohibited
|
|
gptkbp:bfsParent
|
gptkb:Equipoise
|
|
gptkbp:bfsLayer
|
6
|